Covidien
Covidien[edit | edit source]
Covidien plc was a global healthcare leader primarily focused on medical devices and supplies. The company had its roots in a diverse array of historic businesses and brands with a presence in over 150 countries.
Overview[edit | edit source]
Covidien, with its diversified product line, was recognized for its commitment to innovation in patient care. The company was actively involved in producing surgical solutions, vascular therapies, respiratory and patient care.
History[edit | edit source]
- 1903: The company's origins trace back to the founding of the Kendall Company, a manufacturer of cotton and gauze health care products.
- 1990s: The Kendall Company becomes part of Tyco Healthcare, a division of Tyco International.
- 2007: Tyco Healthcare was spun off and became an independent company, adopting the name Covidien.
- 2015: Medtronic, a global leader in medical technology, services, and solutions, acquired Covidien in a deal valued at nearly $50 billion.
Key Divisions and Products[edit | edit source]
- Surgical Solutions: Covidien was a prominent player in the surgical market, providing advanced medical devices for minimally invasive procedures.
- Vascular Therapies: The company produced devices and solutions for vascular diseases, including venous therapies and arterial embolization.
- Respiratory and Patient Care: This division focused on solutions for airway management, ventilators, and patient monitoring.
Research and Development[edit | edit source]
Covidien invested heavily in R&D to ensure continuous innovation in its product lines. They worked closely with the medical community to understand needs and challenges, leading to the development of cutting-edge solutions.
Corporate Responsibility[edit | edit source]
Covidien had an active CSR wing dedicated to social and environmental responsibilities. Their initiatives ranged from reducing their carbon footprint to community outreach programs.
Acquisitions and Mergers[edit | edit source]
Covidien strategically acquired several companies during its tenure, expanding its product range and geographical presence. The most significant was its merger with Medtronic in 2015.
Facilities[edit | edit source]
With its vast global presence, Covidien had manufacturing, R&D, and commercial operations spread across multiple continents.
See Also[edit | edit source]
References[edit | edit source]
- [1] "The Legacy of Covidien". MedTech Dive Magazine.
- [2] "Medtronic-Covidien Merger: A New Beginning". The Wall Street Journal.
- [3] "Covidien's Corporate Responsibility Report". Covidien Official Report.
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD